Clinical Trials for Retinitis Pigmentosa

Find clinical trials for retinitis pigmentosa. Discover research opportunities and treatment options in your area.

48 Active Trials Found

Showing 48 trials on this page

Page 1 of 3

Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

NCT ID: NCT06912633

This clinical trial is looking at the safety of a treatment called jCell (famzeretcel) for adults with Retinitis Pigmentosa (RP), a condition that can lead to vision loss. The study involves giving...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bakersfield, California, United States, Beverly Hills, California, United States +2 more

A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa

NCT ID: NCT06388200

This clinical trial is studying a new gene therapy called OCU400 to see how well it works, how safe it is, and how well patients can tolerate it. The focus is on people with retinitis pigmentosa (R...

Recruiting

Phase: PHASE3 Type: interventional Locations: Houston, Texas, United States, Toronto, Ontario, Canada +14 more

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants

NCT ID: NCT05589714

The Universal Rare Gene Study is a research project aimed at understanding rare genetic causes of retinal dystrophies, like inherited retinal degeneration and retinitis pigmentosa. This internation...

Recruiting

Type: observational Locations: Salt Lake City, Utah, United States, Rochester, Minnesota, United States +43 more

Rod and Cone Mediated Function in Retinal Disease

NCT ID: NCT02617966

This clinical trial is studying how well people can see in the dark and whether this can help doctors understand the severity of certain eye diseases, like retinal degeneration, retinitis pigmentos...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)

NCT ID: NCT06460844

The ENVISION clinical trial is studying a new treatment called RTx-015 injection for patients with Retinitis Pigmentosa, a genetic eye disease that affects vision. This is a Phase 1 study, which me...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beverly Hills, California, United States, Bellaire, Texas, United States +2 more

Cell Collection to Study Eye Diseases

NCT ID: NCT01432847

This clinical trial is focused on studying eye diseases that affect the retina, specifically Best Vitelliform Dystrophy (Best disease), Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macu...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

BS01 in Patients With Retinitis Pigmentosa

NCT ID: NCT04278131

This clinical trial is studying a new treatment called BS01 for people with a condition known as retinitis pigmentosa, which affects vision by damaging the light-sensitive cells in the retina of th...

Recruiting

Phase: PHASE1 Type: interventional Locations: Teaneck, New Jersey, United States, New York, New York, United States

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT ID: NCT01793168

The Coordination of Rare Diseases at Sanford (CoRDS) is a clinical trial aimed at creating a large, centralized registry for individuals affected by rare diseases. This registry helps connect patie...

Recruiting

Type: observational Locations: Sioux Falls, South Dakota, United States, Sydney, , Australia

Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

NCT ID: NCT06242379

This clinical trial is studying the safety and effectiveness of a new treatment for patients with Retinitis Pigmentosa (RP), a condition that affects vision. Researchers are testing a type of treat...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bangkok Noi, Bangkok, Thailand

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

NCT ID: NCT06319872

This clinical trial is studying the effects of a medication called disulfiram (commonly known as Antabuse®) on vision in patients with certain eye conditions that cause vision loss, such as retinal...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, New York, United States

Retinal Imaging in Patients With Inherited Retinal Degenerations

NCT ID: NCT00254605

This clinical trial is focused on studying the eye condition known as retinitis pigmentosa, which is a type of inherited retinal degeneration. The researchers want to learn more about how the retin...

Recruiting

Type: observational Locations: San Francisco, California, United States

Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation

NCT ID: NCT06952842

This clinical trial is studying a new treatment called ZVS203e for people with retinitis pigmentosa (RP), a condition that affects the retina and can lead to vision loss. Specifically, the trial is...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

Study of BEST1 Vitelliform Macular Dystrophy

NCT ID: NCT05809635

This clinical trial is studying a condition called Best Vitelliform Macular Dystrophy (VMD), which affects vision and is caused by changes in a specific gene known as BEST1. The main goal of the st...

Recruiting

Type: observational Locations: New York, New York, United States, Paris, , France +1 more

An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa

NCT ID: NCT06936787

This clinical trial, called a Phase 1 Study, is investigating a new treatment called IGT001 for patients with retinitis pigmentosa, a genetic condition that affects vision. The main goal of the stu...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China

High Resolution Retinal Imaging

NCT ID: NCT01866371

This clinical trial is focused on using a special imaging technique called adaptive optics scanning laser ophthalmoscope (AOSLO) to take detailed pictures of the retina, which is the light-sensitiv...

Recruiting

Type: observational Locations: Philadelphia, Pennsylvania, United States

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAION

NCT ID: NCT05147701

This clinical trial is looking at the safety of using special cells called mesenchymal stem cells, which are taken from umbilical cords, to treat various eye diseases such as retinitis pigmentosa, ...

Recruiting

Phase: PHASE1 Type: interventional Locations: St. John's, , Antigua And Barbuda, Buenos Aires, , Argentina +1 more

Adaptive Optics Imaging of Outer Retinal Diseases

NCT ID: NCT05355415

This clinical trial, titled "Adaptive Optics Imaging of Outer Retinal Diseases," is focused on understanding and diagnosing various outer retinal diseases, such as age-related macular degeneration ...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States, Silver Spring, Maryland, United States

Natural History Study in Patients with PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

NCT ID: NCT06323772

This clinical trial is studying a condition called retinitis pigmentosa, specifically in patients with certain genetic types known as PDE6A, PDE6B, and RHO. The goal of the study is to better under...

Recruiting

Type: observational Locations: Tübingen, Baden Württemberg, Germany, Tübingen, , Germany

Inherited Retinal Degenerative Disease Registry

NCT ID: NCT02435940

The Inherited Retinal Degenerative Disease Registry, known as the My Retina Tracker® Registry, is a study designed for individuals affected by certain rare eye diseases that can lead to vision loss...

Recruiting

Type: observational Locations: Columbia, Maryland, United States

Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene

NCT ID: NCT06291935

This clinical trial is looking at a new gene therapy called VG901 to see if it is safe and effective for people with a rare eye condition called Retinitis Pigmentosa (RP), specifically those with c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tuebingen, , Germany

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions